Crossmark Global Holdings Inc. lessened its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 9.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 9,524 shares of the company’s stock after selling 969 shares during the period. Crossmark Global Holdings Inc.’s holdings in Bath & Body Works were worth $304,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of BBWI. Janney Montgomery Scott LLC bought a new position in shares of Bath & Body Works during the 1st quarter valued at approximately $203,000. Envestnet Portfolio Solutions Inc. increased its stake in shares of Bath & Body Works by 5.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock worth $279,000 after purchasing an additional 277 shares in the last quarter. Russell Investments Group Ltd. lifted its stake in shares of Bath & Body Works by 46.9% during the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock valued at $6,572,000 after buying an additional 41,995 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in Bath & Body Works by 12.9% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 350,726 shares of the company’s stock worth $17,589,000 after buying an additional 40,178 shares during the period. Finally, Vanguard Group Inc. increased its stake in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after buying an additional 1,102,124 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Bath & Body Works Price Performance
Shares of BBWI stock opened at $31.54 on Monday. The company has a market cap of $6.91 billion, a PE ratio of 7.64, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The stock’s 50 day simple moving average is $30.18 and its two-hundred day simple moving average is $36.38.
Bath & Body Works Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.54%. Bath & Body Works’s dividend payout ratio is presently 19.37%.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. Morgan Stanley lowered their price objective on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. UBS Group lowered their price target on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Citigroup cut their price objective on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. JPMorgan Chase & Co. lowered their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Finally, Wells Fargo & Company reduced their price target on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $42.44.
View Our Latest Research Report on Bath & Body Works
Insider Activity at Bath & Body Works
In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.27% of the stock is currently owned by insiders.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
See Also
- Five stocks we like better than Bath & Body Works
- Buy P&G Now, Before It Sets A New All-Time High
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.